DSIP Research for Chronic Pain
An evidence-based overview of research examining DSIP in the context of chronic pain. This page synthesizes findings from peer-reviewed literature.
Research Summary
Evidence for analgesic effects is limited to animal work. In mice and rats, centrally administered DSIP produced dose-dependent antinociception that was reversed by the opioid antagonist naloxone and was absent in morphine-tolerant animals, indicating an opioid-receptor-mediated mechanism. No human pain trials have been published.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. DSIP may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.